We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$2.9B
AUM Growth
+$137M
Cap. Flow
+$88.8M
Cap. Flow %
3.06%
Top 10 Hldgs %
17.97%
Holding
1,008
New
71
Increased
442
Reduced
400
Closed
82

Top Buys

Rank Stock Value
1
VGM icon
Invesco Trust Investment Grade Municipals
VGM
+$4.8M
2
NMZ icon
Nuveen Municipal High Income Opportunity Fund
NMZ
+$4.39M
3
MQY icon
BlackRock MuniYield Quality Fund
MQY
+$4.26M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.84M
5
OLMA icon
Olema Pharmaceuticals
OLMA
+$3.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$19.8M
2
ETNB
89bio
ETNB
+$3.65M
3
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$3.59M
4
RKLB icon
Rocket Lab Corp
RKLB
+$3.39M
5
VMO icon
Invesco Municipal Opportunity Trust
VMO
+$3.16M

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 11.66%
3 Financials 9.01%
4 Industrials 7.22%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WU icon
576
Western Union
WU
$2.16B
$804K 0.03%
86,366
-31,205
-27% -$276K
AKBA icon
577
Akebia Therapeutics
AKBA
$245M
$803K 0.03%
+498,961
New +$1.04M
EGP icon
578
EastGroup Properties
EGP
$10.9B
$801K 0.03%
4,494
+328
+8% +$58.3K
STAG icon
579
STAG Industrial
STAG
$7.09B
$800K 0.03%
21,773
+2,152
+11% +$81.7K
IBRX icon
580
ImmunityBio
IBRX
$8.09B
$797K 0.03%
402,639
+95,855
+31% +$217K
NVMI
581
Nova
NVMI
$13B
$792K 0.03%
2,413
+1,180
+96% +$379K
REGN icon
582
Regeneron Pharmaceuticals
REGN
$81.8B
$786K 0.03%
1,018
-29
-3% -$19.7K
MD icon
583
Pediatrix Medical
MD
$2.13B
$783K 0.03%
36,598
+4,735
+15% +$97K
EOG icon
584
EOG Resources
EOG
$74.6B
$778K 0.03%
7,410
+2,523
+52% +$271K
CPB icon
585
Campbell Soup
CPB
$6.68B
$778K 0.03%
27,910
-7,649
-22% -$230K
ALT icon
586
Altimmune
ALT
$609M
$775K 0.03%
214,632
+29,057
+16% +$127K
NXPI icon
587
NXP Semiconductors
NXPI
$59.6B
$772K 0.03%
3,556
+481
+16% +$103K
MKTX icon
588
MarketAxess Holdings
MKTX
$5.72B
$770K 0.03%
4,249
+544
+15% +$92.8K
ALV icon
589
Autoliv
ALV
$8.82B
$762K 0.03%
6,420
+1,087
+20% +$130K
VISN
590
Vistance Networks Inc
VISN
$2.69B
$755K 0.03%
41,643
+13,274
+47% +$229K
FDUS icon
591
Fidus Investment
FDUS
$749M
$749K 0.03%
38,831
-3,147
-7% -$62.6K
HCSG icon
592
Healthcare Services Group
HCSG
$1.44B
$744K 0.03%
38,912
+5,009
+15% +$90.1K
TSLX icon
593
Sixth Street Specialty
TSLX
$1.78B
$744K 0.03%
34,249
-1,032
-3% -$22.5K
CHE icon
594
Chemed
CHE
$6.99B
$742K 0.03%
1,734
-46
-3% -$20K
VCLT icon
595
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.76B
$739K 0.03%
9,748
+848
+10% +$65.4K
PDD icon
596
Pinduoduo
PDD
$127B
$737K 0.03%
6,502
+252
+4% +$31.3K
TSN icon
597
Tyson Foods
TSN
$19.6B
$734K 0.03%
12,521
-209
-2% -$11.5K
IDT icon
598
IDT Corp
IDT
$1.62B
$730K 0.03%
14,262
+2,080
+17% +$104K
OKE icon
599
Oneok
OKE
$57.6B
$726K 0.03%
9,872
-315
-3% -$22.3K
COLB icon
600
Columbia Banking Systems
COLB
$9.01B
$725K 0.03%
25,935
+6,316
+32% +$171K
22 23
24
25 26

Similar funds

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Hennion & Walsh Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Hennion & Walsh Asset Management held 1,008 positions worth $2.9B, up 5% from $2.76B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management deployed $88.8M of net new capital in Q4 2025, opening 71 new positions and adding to 442 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Rhythm Pharmaceuticals, an estimated $3.59M trimmed.

  • Hennion & Walsh Asset Management's largest Q4 2025 buy was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.
  • Hennion & Walsh Asset Management added most to Invesco Trust Investment Grade Municipals in Q4 2025, an estimated $4.8M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2025 reduction was Rhythm Pharmaceuticals, cutting an estimated $3.59M.
  • Hennion & Walsh Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $19.8M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $2.9B portfolio in Q4 2025.
  • Hennion & Walsh Asset Management opened 71 new positions and closed 82 in Q4 2025.
  • Hennion & Walsh Asset Management's portfolio value rose 5% quarter-over-quarter to $2.9B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2025, filed 14 Jan 2026.